The Hon Ron Phillips (AO) - Managing Director
Following 15 years in the NSW Parliament which included serving as Minister for Health and Deputy Leader of the Opposition, Ron developed a successful consulting business in the Health and Aged Care Industry.
His business interests included co-owner and Managing Director of Sydney Breast Clinic which he sold to Healthscope. He currently serves as Chair of the Sydney Local Health District and as Director on Westmead IVF.
Jayne Shaw – Chairman
Jayne Shaw trained as a Registered Nurse in the UK, on arrival in Australia she became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this she established an Australian and International consulting business which was sold to Healthsouth a large US Healthcare company. After this she became the Co-founder of Vision Group an Opthalmic Doctor equity consolidation model which was successfully listed on the ASX.
Jayne joined a number of private Healthcare Boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women’s Health she continued to work with Private Equity firms on local and International Healthcare transactions. Jayne, together with Ron Phillips was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics.Current Board positions are Critical Group – Heatley’s Industrial Supplies, The Woolcock Research Institute, and The Hareda Foundation established to invest in Women’s Health Initiatives.
Carl Stubbings – Head of Commercialisation
Carl Stubbings is a highly qualified senior executive with over thirty years experience in biotechnology and medical diagnostics. His background includes manufacturing, administration, and extensive international sales and marketing expertise in North America, Latin America, Asia Pacific and Europe.
Prior positions include:
• Chief Business Officer Benitec Biopharma (ASX: BLT)
• Vice President Sales & Marketing for Focus Diagnostics a subsidiary of Quest Diagnostics (NASDAQ; DGX)
• Senior Vice President Panbio Ltd (USA)
• Current board appointments include Analytica Medical (ASX: ALT), Sienna Cancer Diagnostics Unlisted Public Company (SCDU) and Otakaro Pathways New Zealand based Private Company.
In his role at Panbio (USA) and Focus Diagnostics, Carl led the commercialisation of number of medical diagnostic products. These achievements include the development and first FDA cleared test for West Nile Virus (Panbio USA). First FDA cleared molecular test for H1N1 (Influenza) and range of other ‘first in class’ molecular tests for viral diseases (Focus Diagnostics).
Prior to moving back to Australia, Carl and his family had lived and worked in the USA for more than 12 years.
Carl holds a B.App.Sc. from the Queensland University of Technology; he holds dual Australian and US citizenship.
Johnathan Trollip – Commercial Consultant
Jonathan is a globally experienced independent director with over 30 years commercial, corporate, governance and legal and transactional expertise.
Jonathan is currently non-executive independent chairman of ASX listed Global Value Fund Ltd Future Generation Investment Company Ltd , Antipodes Global Investment Company Ltd and Plato Income Maximizer Limited . He is a non-executive director of ASX listed Kore Potash Limited and holds private company directorships in the commercial and not-for-profit sectors.
Jonathan was a principal of Sydney, Australia based structured finance group Meridian International Capital Limited for over 20 years, Prior to that, Jonathan was a partner with law firm Herbert Smith Freehills). Jonathan currently has a New South Wales Law Society Practicing Certificate and is a Fellow of the Australian Institute of Company Directors.
Dr. Dharmica Mistry (PhD) – Chief Scientist
Dr. Dharmica Mistry is the Company’s senior scientist. Dharmica holds a BSc (Hons) from Sydney University, majoring in Microbiology, and has completed a PhD at Macquarie University that was based on examining the association of lipids in hair and serum with the presence of breast cancer. Dharmica is an inventor on one of the Company’s founding patents and manages the scientific operations of the company. Dharmica has worked in the Australian biotechnology industry since 2007.
In 2015 Dharmica graduated with a distinction from the NSW Health Medical Devices Commercialisation Training Program. In 2016 Dharmica was the recipient of the “NSW Young Woman of the Year” award for which she was nominated by the Minister of Health, Jillian Skinner. She was also announced as Young Executive of the Year (2016) in Australia by the Australian Financial Review (AFR) Boss Magazine.